Skip to Search Global Search Investors Media Healthcare professionals Partnerships Consumers Business to business Contact us About us Products Our stories Careers Research Responsibility #leaderinrespiratory: see the film We are a science-led global healthcare company with a mission: we want to help people to do more, feel better, live longer. Watch our story News Positive CHMP opinion for novel anti-IL5 biological Nucala (mepolizumab) for treatment of patients with severe refractory eosinophilic asthma Read more about this story Discover our history in R&D Our news GSK presents post-hoc analysis of Anoro® Ellipta® data assessing markers of COPD deterioration compared to tiotropium or placebo using a novel composite endpoint 27 September 2015 GSK receives positive CHMP opinion in Europe for novel anti-IL5 biological Nucala (mepolizumab) for the treatment of patients with severe refractory eosinophilic asthma 24 September 2015 Regulatory update: GSK and Theravance announce intention to file Relvar® Ellipta® for COPD in Japan 24 September 2015 See more press releases Corporate reporting Read our Annual Report (PDF) Read our Responsible Business Supplement (PDF) Corporate reporting archive Join the conversation Follow us on Twitter Like us on Facebook Watch us on YouTube Visit us on Flickr Follow us on LinkedIn Follow us on Google+ Tweets from GSK We’re working with athletes @GSK_HPL to break the boundaries of human performance: gsk.to/1PSAuVQ 5 hours ago Through @MaxiNutrition we can provide #rugby players like @ChrisRobshaw with optimal nutrition. Read more at gsk.to/1M6f2Jj 5 hours ago Follow us on Twitter Explore our products We make a wide range of prescription medicines, prescribed vaccines and consumer healthcare products. Our prescription medicines and vaccines Our consumer healthcare products... Working at GSK Find out about working at GSK and how to apply for a job. Explore careers at GSK Report a possible side effect Tell us about a possible side effect you may have experienced Information for investors Share price London 1,281.50 +13.50 Share price at 4:35 PM GMT NYSE 39.50 +0.76 Share price at 4:04 PM EST LSE and NYSE price updated every 15 & 20 minutes respectively Full year 2014 results Investing in GSK Share price analysis View our investors section Clinical trial information Clinical Study Register Data transparency Sitemap Terms of use Accessibility Cookie policy Privacy Statement GSK employees © 2001-2015 GSK group of companies. All rights reserved. GlaxoSmithKline plc. Registered in England and Wales No. 3888792. Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.